Celebrating science, collaboration and excellence at WIMM Day 2025
1 July 2025
The MRC WIMM community gathered for its flagship annual event, WIMM Day, on Tuesday 24th June. Held at the Saïd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
Rare Disease Day 2025
27 February 2025
For Rare Disease Day on the 28th February, we spoke to three of our researchers about their work, discussing both the challenges and importance of researching and treating rare diseases.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
18 teams in the MRC WIMM receive LEAF Sustainability awards
17 July 2024
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research laboratories to embed sustainability into their work.
New study shines light on the complex mechanisms of Fetal Growth Restriction in pregnancy
29 July 2022
The paper, published in Nature Communications reveals key genes involved in the common developmental disease.
Seven research groups secure LEAF Sustainability Awards
22 July 2022
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.
Spatial transcriptomics of neurodegeneration in Progressive Multiple Sclerosis (MS)
28 June 2022
In a paper published in Nature Neuroscience, the Fugger Group describe molecular pathways of MS neurodegeneration in unprecedented detail.
Funding awarded for autoimmune disease research
13 May 2022
Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.
Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis
16 February 2021
MRC WIMM researchers have revealed a population of immune cells that travel to the brain in patients with multiple sclerosis causing disease. They demonstrate how to trap these cells in the blood, meaning they can be targeted to prevent disease progression.
Angela Vincent honoured for excellence in epilepsy research
17 December 2019
Emeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.
New research to investigate role of blood-brain barrier
12 February 2019
A new consortium of 27 partners coordinated by our researcher Prof Zameel Cader will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics.
European licence for migraine prevention drug
31 July 2018
MRC WIMM research underpins the first treatment designed specifically for the prevention of migraines
World’s largest autism grant will transform research landscape
18 June 2018
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium that includes the participation of Prof Zameel Cader.
Oxford Centre for Neuroinflammation launched
30 May 2018
The new centre, located at the MRC WIMM, aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.